Limbix is a brand that specializes in providing evidence-based digital therapeutics to address mental health conditions, particularly in adolescents and young adults. As a leader in digital therapeutics, Limbix offers SparkRx, the first-ever digital therapeutic designed specifically for teens and young adults with symptoms of depression. This therapeutic program, developed by an interdisciplinary team of experts in adolescent psychology, utilizes self-guided cognitive behavioral therapy (CBT) methods to teach skills such as mood tracking, behavioral activation, problem-solving, and mindfulness.

In addition to SparkRx, Limbix is also developing an adolescent anxiety product to further expand their therapeutic portfolio. This acquisition by Big Health, the leading provider of non-drug digital treatments for mental health, allows Limbix to join forces and combine their resources to address the growing youth mental health crisis. By leveraging their research-based pipeline of adolescent products, Limbix and Big Health aim to provide immediate access to safe and effective non-drug options for both adult and adolescent patients.

Through their innovative and clinically-proven digital depression treatments, Limbix and Big Health strive to help millions of individuals achieve good mental health by breaking down barriers to care and offering accessible solutions for the most common mental health conditions